SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is trending amid reports of potential partnerships and investments from major players like Apple and TSMC, fueling optimism about its comeback in the semiconductor industry. The community is actively discussing the potential impact of these deals, as well as government support, on Intel's future market position. This buzz is occurring within the broader context of the US aiming to bolster its domestic chip production capabilities.

Cipher Mining, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Mining Inc

Cipher Mining (CIFR) is trending due to the announcement of an upsized convertible bond offering and a related hosting agreement with Fluidstack, backed by Google, leading to significant price volatility. While some investors express concerns about potential dilution, others view the developments as a sign of strong market confidence and a catalyst for growth in mining capacity and high-performance computing. The community is actively debating the long-term implications of the offering and its impact on the stock's trajectory.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending as traders assess recent market volatility and economic data, including GDP revisions and jobless claims, influencing speculation around future Fed policy. Community discussions revolve around potential market direction, the impact of tariffs, and whether the current pullback represents a buying opportunity or the start of a larger correction. Some are concerned about overvalued tech stocks and potential market manipulation, while others remain bullish, anticipating a continued rally.

Pupu is a community-driven meme project centered around the character “Pupu the Frog,” who represents lighthearted fun and adventure within the crypto space. The project aims to build a digital ecosystem where holders can engage with the narrative of Pupu through memes, social interactions, and community activities. At its core, the project highlights creativity, entertainment, and community participation as primary utilities, while maintaining a transparent and decentralized structure that evolves through user engagement.

Pupu

$PUPU.X is gaining traction as a potential successor in the meme coin space, drawing comparisons to $PEPE and other Solana-based tokens. Community members are actively monitoring its chart and volume, emphasizing the ease of access through Phantom Wallet. The focus remains on its potential for significant growth within the broader crypto market.

Lithium Americas Corp. engages in the development of the Thacker Pass project. It is focused on advancing Thacker Pass to production it is located in northern Nevada. The company was founded on January 23, 2023 and is headquartered in Vancouver, Canada.

Lithium Americas Corp (NewCo)

Lithium Americas Corp

LAC is trending as reports circulate that the U.S. government may take a stake in the company, tied to its DOE loan, sparking debate about government involvement in for-profit business. The community is discussing the potential for a short squeeze and comparing it to similar situations with MP Materials and Intel, while also considering the impact on lithium supply chains and national security. Some traders are pointing to technical indicators and overnight trading activity, while others express skepticism about the company's fundamentals and potential dilution.

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

$BROKE.X is trending as its community rallies around recent listings and developments, emphasizing their strong holder conviction. Community members are actively discussing the coin's potential for a rebound and encouraging others to 'buy the dip.' There is also discussion of a potential massive burn at 2500 watchers.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X Shares

Direxion Daily Semiconductor Bear 3X Shares

SOXS is trending as traders react to potential shifts in the semiconductor landscape, particularly influenced by Intel's recent activity and news regarding potential import restrictions. Community discussions revolve around whether the current semi surge is sustainable, with many pointing to AI hype and government intervention as key factors. Some traders are looking at SOXS as a potential hedge against an overvalued market, while others believe the sector still has room to run.

Costco Wholesale Corp. engages in the provision of operation of membership warehouses through wholly owned subsidiaries. It operates through the following geographical segments: United States, Canada, and Other International Operations. The company was founded by James D. Sinegal and Jeffrey H. Brotman in 1983 and is headquartered in Issaquah, WA.

Costco Wholesale Corp

Despite a recent earnings beat, Costco's stock is trending as the community debates whether the valuation is justified, especially with tariffs looming. Community members are closely watching membership fee revenue and same-store sales data for indications of future performance. The stock's high PE ratio is also a key point of discussion, with some suggesting it's overvalued compared to growth prospects.

Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly. The firm is also developing other oral nonpeptide somatostatin agonists for neuroendocrine tumors and hyperinsulinism, as well as an oral nonpeptide ACTH antagonist for the treatment of Cushing's disease. The company was founded by R. Scott Struthers, Yun-Fei Zhu and Stephen F. Betz in 2008 and is headquartered in San Diego, CA.

Crinetics Pharmaceuticals Inc

Crinetics Pharmaceuticals is trending due to FDA approval of their oral acromegaly drug, Palsonify, driving significant retail investor chatter. The community is focused on the potential for a short squeeze given high institutional ownership and short interest, alongside discussions about revenue projections and buyout possibilities. Broader sentiment suggests optimism regarding the drug's market potential and impact on patient care.

Eason Technology Ltd. engages in the provision of loan facilities to micro, small and medium size enterprises, and sole proprietors. It also offers microfinance lending services. The company was founded by Qi Ming Xu and Kang Kai Zeng on June 24, 2010 and is headquartered in Wuhan, China.

Eason Technology Ltd. - ADR

Eason Technology Ltd ADR

DXF is trending as traders discuss its low float and potential for a significant breakout, drawing comparisons to other stocks with similar characteristics that have recently experienced substantial gains. Community members are speculating on upcoming news or PR related to compliance or cryptocurrency initiatives as potential catalysts. Despite some skepticism and concerns about potential pump-and-dump schemes, many are accumulating shares, anticipating a substantial price increase.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

TScan Therapeutics, Inc. (TCRX) Reports Q2 Loss, Beats Revenue Estimates

TScan Therapeutics (TCRX) delivered earnings and revenue surprises of 0.00% and +58.07%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Urogen Pharma (URGN) Reports Q2 Loss, Lags Revenue Estimates

Urogen Pharma (URGN) delivered earnings and revenue surprises of -28.05% and -0.96%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Mirum Pharmaceuticals, Inc. (MIRM) Reports Q2 Loss, Tops Revenue Estimates

Mirum Pharmaceuticals (MIRM) delivered earnings and revenue surprises of +61.29% and +17.88%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Twist Bioscience (TWST) Reports Q3 Loss, Tops Revenue Estimates

Twist Bioscience (TWST) delivered earnings and revenue surprises of +12.96% and +0.60%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Demystifying TScan Therapeutics: Insights From 4 Analyst Reviews

Latest Ratings for TCRX
 DateFirmActionFromTo Dec 2021HC Wainwright & Co.Initiates Coverage OnBuy Aug 2021Cowen & Co.Initiates Coverage OnOutperform Aug 2021Morgan StanleyInitiates Coverage...

Expert Outlook: TScan Therapeutics Through The Eyes Of 5 Analysts

TScan Therapeutics (TCRX) Gets a Buy from Wedbush

In a report released today, David Nierengarten from Wedbush assigned a Buy rating to TScan Therapeutics (TCRX Research Report), with a price targ...

Buy Rating Affirmed for TScan Therapeutics Amidst Strong Pipeline Progress and Robust Financial Health

In a report released yesterday, Sam Slutsky from LifeSci Capital maintained a Buy rating on TScan Therapeutics (TCRX Research Report), with a pri...

Analysts Are Bullish on These Healthcare Stocks: Aprea Therapeutics (APRE), TScan Therapeutics (TCRX)

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Aprea Therapeutics (APRE Research Report) and TScan Therapeutics...

TScan Therapeutics (TCRX) Gets a Buy from TD Cowen

In a report released today, Tara Bancroft from TD Cowen maintained a Buy rating on TScan Therapeutics (TCRX Research Report). The company's share...

TScan Therapeutics, Inc. discovers and develops transformative T cell therapies (TCR-T) to treat liquid cancers, solid tumors and other serious diseases. Its platform identifies previously uncharacterized, clinically-derived shared T cell antigens and all off-target TCR interactions, to enable the development of efficacious TCR-Ts. The company was founded by Christoph H. Westphal, Stephen Elledge, Lea Hachigian, and Tomasz Kula in 2018 and is headquartered in Boston, MA.

Tscan Therapeutics Inc

$5,000

$6,000

$7,000

$8,000

What price will Ethereum hit in 2025? 
 
*Powered by Polymarket

Current Price	$1.78
Prev Close	$1.84
Open	$1.84
Dividend Yield	0.00%
50-Day Moving Average	$1.79
Beta	0.92
Avg. Volume	217,295.24
PE Ratio	-1.68

52-Week High	$6.23
52-Week Low	$1.02
Market Capitalization	$104.42M
EPS (Annual)	-$1.14
Price to Book	0.59
Revenue Per Employee	$14,515.46
Enterprise Value/EBITDA	N/A

TCRX
Tscan Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest TCRX News

TCRX Tscan Therapeutics Inc